We welcome collaboration from potential investigators provided that any new studies relate to the field of urological research.

If you would like to use ProtecT Study data for a new research study or a publication, please complete the Access to data and/or samples from the ProtecT study Proforma (Office document, 29kB) as the means to seek approval from the ProtecT study PIs.

All manuscripts must adhere to the ProtecT study: Publication and authorship policy August 2016 (PDF, 287kB) 

Specific acknowledgement of the funders must be included in each publication.  For ProtecT, it must state that:

Funding/publication acknowledgement This project was funded by the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Programme, HTA 96/20/99; ISRCTN20141297 and will be published in full in the [insert journal title, volume and issue number, if known]. Further information available at: [insert project page web address] 

Department of Health disclaimer This report presents independent research commissioned by the National Institute for Health and Care Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, MRC, CCF, NETSCC, the UK National Institute for and Care Health Research (NIHR) Health Technology Assessment (HTA) Programme or the Department of Health.

NB there is a separate one for where quotes from interviews are used:

This report presents independent research commissioned by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Programme or the Department of Health. The views and opinions expressed by the interviewees in this publication are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, MRC, CCF, NETSCC, the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Programme or the Department of Health.

If ProMPT data or samples are used, a separate acknowledgement must be included (to be obtained from the PIs).  A footnote must also be included in all publications listing names of the local investigators and other appropriate research staff within the ProtecT study (details to be provided by Dr Lane).

The HTA wish to receive all publications relating to ProtecT 28 days in advance of publication. Please email the pdf to Athene Lane, athene.lane@bris.ac.uk, to forward to HTA.

BRTC Acknowledgement Statement All BRTC adopted studies should acknowledge the BRTC in publications and presentations by using the following wording;

Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, UK.

This study was designed and delivered in collaboration with the Bristol Randomised Trials Collaboration (BRTC), a UKCRC registered clinical trials unit which, as part of the Bristol Trials Centre, is in receipt of National Institute for Health and Care Research CTU support funding.

If your trial is using REDCap (Research Electronic Data Capture) to collect the trial data you must also cite the REDCap project in all publications, an example is below:

“Study data were collected and managed using REDCap (Research Electronic Data Capture, Harris PA, et al. J Biomed Inform. 2009 Apr;42(2):377-81) hosted at the University of Bristol”

 

Please email the completed forms to nicky.iyer@nds.ox.ac.uk